Rv0667 - p.Asp435Asn
Drug resistance types
0 Sensitive
2 RR-TB
0 HR-TB
17 MDR-TB
7 Pre-XDR-TB
0 XDR-TB
0 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.1 | 8 |
| lineage4.4.2 | 3 |
| lineage1.2.1.2.1 | 3 |
| lineage4.2 | 1 |
| lineage4.2.2 | 1 |
| lineage4.1.1.3;lineage3 | 1 |
| lineage1.1.1.1 | 1 |
| lineage4.3.3 | 1 |
| lineage4.1.2.1.1 | 1 |
| lineage3 | 2 |
| lineage2.2.1.1 | 1 |
| lineage3.1.2;lineage2.2.1.1 | 2 |
| lineage4.3.2 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 26 |
Geographic prevalence
Country level data for this variant is available for 7 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | ERR7737639 | MDR-TB | lineage2.2.1 | None | SRR11567789 | Pre-XDR-TB | lineage4.4.2 | None | SRR069983 | MDR-TB | lineage1.2.1.2.1 | None | SRR11567800 | Pre-XDR-TB | lineage4.4.2 | None | SRR069991 | MDR-TB | lineage1.2.1.2.1 | None | SRR13423567 | Pre-XDR-TB | lineage4.2 | None | SRR20969745 | Pre-XDR-TB | lineage4.2.2 | None | SRR15465773 | Pre-XDR-TB | lineage4.1.1.3;lineage3 | None | SRR18054810 | MDR-TB | lineage2.2.1 | None | DRR261159 | MDR-TB | lineage1.1.1.1 | None | SRR3085261 | MDR-TB | lineage2.2.1 | None | SRR1723752 | MDR-TB | lineage2.2.1 | cn | SRR6824378 | RR-TB | lineage2.2.1 | cn | SRR3086353 | MDR-TB | lineage2.2.1 | None | ERR11488511 | MDR-TB | lineage4.3.3 | None | SRR6824344 | MDR-TB | lineage2.2.1 | cn | ERR760858 | MDR-TB | lineage4.1.2.1.1 | ar | SRR5007165 | MDR-TB | lineage3 | None | SRR20969384 | MDR-TB | lineage2.2.1.1 | None | ERR4796867 | MDR-TB | lineage3.1.2;lineage2.2.1.1 | in | ERR2512606 | MDR-TB | lineage3 | None | ERR2516124 | RR-TB | lineage4.3.2 | None | SRR8651637 | Pre-XDR-TB | lineage4.4.2 | cn | ERR4796852 | MDR-TB | lineage3.1.2;lineage2.2.1.1 | in | SRR067471 | MDR-TB | lineage1.2.1.2.1 | None | SRR7653610 | Pre-XDR-TB | lineage2.2.1 | None |
|---|
